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Morphogenesis of some tissues and organs in the developing embryo requires the transformation of epithelial cells into
mesenchyme followed by cell motility and invasion of surrounding connective tissues. Details of the mechanisms involved
in this important process are beginning to be elucidated. The epithelial-mesenchymal transformation (EMT) process
involves many steps, one of which is the upregulation and activation of specific extracellular proteinases including members
of the matrix metalloproteinase (MMP) family. Here we analyze the role of MMPs in the initiation of the mesenchymal cell
phenotype in the developing heart, and find that they are necessary for the invasion of mesenchymal cells into the
extracellular matrix of the endocardial cushion tissues. An important requirement in the formation of this mesenchyme is
the turnover of type IV collagen along the basal surface of endocardial cells. In vitro experiments suggest that type IV
ollagen does not provide a suitable migratory substrate for endocardial cushion cells unless MMP-2 and MT-MMP are
ctive. Relevant MMPs were found to be upregulated by factors known to be involved in the induction of the EMT such as
GFb3. These results provide evidence of an important role for MMPs during a specific stage of the epithelial mesenchymal
ransformation in the embryonic heart, and suggest that specific cell-matrix interactions which facilitate cell migration only
ccur when the composition of the surrounding extracellular matrix is proteolytically altered. © 2000 Academic Press
Key Words: epithelial-mesenchymal transformation; endocardial cushions; matrix metalloproteinases; extracellular
matrix; embryonic heart development; type IV collagen.E
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The transformation of epithelial cells into mesenchyme
is a unique and basic process which occurs during embry-
onic development and is important in the morphogenesis of
organs and tissues in the embryo. The epithelial-
mesenchymal transformation (EMT) has been shown to
occur at discrete sites and at specific times in the embryo,
and gives rise to a population of elongated, highly motile
cells which invade the surrounding extracellular matrix
(Hay, 1995; Hay and Zuck, 1995). In some cases, these cells
can migrate to sites in the embryo which are considerable
distances from the originating epithelium. Examples of the
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of Medicine, 915 Camino de Salud, N.E., Albuquerque, NM 87131.aFax: (505) 272-9105. E-mail: pmcguire@salud.unm.edu.
606MT process include the transformation of the ventral
ortion of the somite into sclerotome cells which contrib-
te to the formation of the vertebral column (Balling et al.,
996), the fusion of the palatal structures through the
ransformation of the midline epithelial seam (Shuler et al.,
992; Shuler, 1995), and the formation of the neural crest
hich differentiate into a wide variety of cell types includ-
ng melanocytes of the skin, various components of the
eripheral nervous system, and a variety of skeletal and
onnective tissue structures (Duband et al., 1995).
This study focuses on the EMT which occurs in the
ndocardial cushions during the early stages of heart devel-
pment (Markwald et al., 1996). At a specific stage of
evelopment endocardial cells of the cushions form mesen-
hyme which invades the underlying cardiac jelly matrix.
hese cells eventually differentiate into the connective
issue cells of the valves and contribute to portions of the
trial and ventricular septae. This process appears to be
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607Matrix Metalloproteinases in the Developing Heartdriven by signals derived from the underlying myocardium
in the form of extracellular matrix (ECM) components
and/or specific growth factors. The response of the endocar-
dium to these signals is characterized by cellular hypertro-
phy and decreased cell-cell adhesion, followed by the
upregulation of specific genes which establish the mesen-
chymal phenotype and promote cell migration and prolif-
eration. (Markwald et al., 1979; Potts et al., 1989, 1991;
Nakajima et al., 1994; Huang et al., 1995; Romano and
Runyan, 2000).
The migration of mesenchymal cells in the endocardial
cushions and other regions of the embryo involves interac-
tions of the cells with components of the ECM which may
be regulated in part by the production of specific extracel-
lular proteinases. These enzymes may facilitate cell migra-
tion by a limited proteolysis of the ECM at cell/substrate
attachment sites, or through a larger scale remodeling of the
matrix, altering the regulatory information contained
within the migratory pathways (i.e., guidance, migratory,
and adhesive cues). One group of extracellular enzymes
which are expressed and may play a critical role in this
process is the matrix metalloproteinases (MMPs). The 72-
kDa type IV collagenase/gelatinase, MMP-2, is expressed in
a variety of tissues of the developing embryo, and has been
reported to degrade a wide variety of matrix components
including fibronectin, vitronectin, and types IV and V
collagen (Matrisian, 1992; Aimes and Quigley, 1995;
Baramova and Foidart, 1995; Imai et al., 1995). Previous
studies have demonstrated that MMP-2 can be localized to
the surface of invasive cell types through an interaction
with the avb3 integrin (Brooks et al., 1996). This interac-
ion not only creates localized areas of controlled proteo-
ytic activity facilitating cell invasion but also has the
otential of effecting the interactions of this integrin with
omponents of the matrix (Deryugina et al., 1997). Based
pon these studies it is not unreasonable to assume that
ppropriate levels of active MMP-2 may directly affect the
bility of cells to migrate into and through the ECM.
We have previously shown that MMP-2 is present in the
eart of the developing quail embryo, and is expressed
pecifically by the endocardium and mesenchyme of the
ushion tissues (Alexander et al., 1997). The level of the
2-kDa pro-form of MMP-2 remained fairly constant during
he early stages of cushion tissue morphogenesis. This was
n marked contrast to the levels of the lower molecular
eight active species which increased significantly during
he transformation of the endocardium. Coincident with
he appearance of the active form of MMP-2 was an increase
n the message levels for the membrane-type matrix met-
lloproteinase (MT-MMP), an activator of pro-MMP-2.
hese results suggested that a key step in the regulation of
MP-2 activity during heart development may be at the
evel of proenzyme activation.
The present study was designed to determine a functional
ole for the matrix metalloproteinases during the EMT
rocess in the endocardial cushions. Results from this study
uggest that active MMPs are critical during the EMT and
Copyright © 2000 by Academic Press. All righthe establishment of the invasive phenotype, and that
pecific components of the cushion extracellular matrix
ust be degraded in order for the mesenchyme to form
ormally.
MATERIALS AND METHODS
All cell culture materials were obtained from Gibco/BRL (Gaith-
ersburg, MD) except for fetal calf serum, which was purchased from
HyClone (Logan, UT). The anti-smooth muscle actin antibody
Clone 1A4 was purchased from Sigma Chemical (St. Louis, MO).
Anti-chicken type IV collagen antibody IIB12 was the kind gift of
Dr. Thomas Linsenmayer (Tufts University School of Medicine,
Boston, MA). The secondary antibody used for this study was
fluorescein-isothiocyanate (FITC)-goat anti-mouse IgG Fab92 from
Jackson Laboratories (West Grove, PA). Purified extracellular ma-
trix proteins, fibronectin, type IV collagen, laminin, and tenascin
were purchased from Gibco/BRL. The matrix metalloproteinase
inhibitor, BB-94, and its nonactive form, BB-1722, were supplied by
British Biotech Pharmaceuticals, Inc.
Embryos and Tissue Isolation
Quail embryos (Coturnix coturnix japonica) were used for these
studies. Fertilized eggs were obtained from B&D Game Farm
(Harrah, OK) and were incubated at 38°C and 60% relative humid-
ity. The embryos were staged according to Zacchei and used
between stages 12 and 24 of development corresponding to specific
developmental events within the endocardial cushions of the
developing heart. At stage 12, the cushion tissues are beginning to
form, and the heart is in the process of looping. The epithelial-
mesenchymal transformation and the seeding of mesenchyme
begins at stage 15–16. By stage 18, the cushion tissues have fully
formed and the epithelial-mesenchymal transformation is well
underway and a population of mesenchymal cells has invaded the
cushion tissue extracellular matrix. By stage 24 of development,
the cushion tissue matrix is heavily populated with mesenchyme
derived from the endocardium. In some experiments, the atrioven-
tricular canal (AVC) was separated from the outflow tract and
ventricular portions of the stage 15–16 embryonic heart and used
for explant culture of endocardial and mesenchymal cells as
described below.
Embryo Culture and Microinjection Techniques
Live quail embryos were grown in a shell-less culture system
allowing direct access to the embryos for microinjection of the
metalloproteinase inhibitors (Dunn et al., 1981). Following 2 days
of incubation, the egg shell was opened and the egg contents were
poured into a plastic sling and incubated in a humidified incubator
at 38°C. When the embryos reached stage 12–14 of development, 5
mM of the appropriate material was injected with a glass micropi-
pett directly into the ventricular portion of the heart. Injections of
this type have resulted in significantly less embryonic demise
compared to injections into the yolk sac vasculature and can
directly target the endocardium of the cushion tissues. Following
injection, the embryos were returned to the incubator and were
allowed to develop until stage 16, 18, or 24 of development at
which time they were collected for immunochemical, histological,
or proteinase analysis.
s of reproduction in any form reserved.
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608 Song, Jackson, and McGuireHistological and Immunocytochemical Analysis
The extent of mesenchyme invasion into the stage 18 endocar-
dial cushions was quantitated in control (BB-1722 or vehicle) and
BB-94 inhibitor-injected embryos. Embryos were collected, fixed
for 3 h in 0.1 M PO4 buffer containing 4% paraformaldehyde, and
embedded in paraffin. Serial 6-mm cross sections of the AVC
ortion of the heart were cut and mounted onto glass slides and
overslipped using Vectashield mounting medium with DAPI
Vector Labs, Burlingame, CA). Images were captured using a video
amera mounted on a Zeiss inverted microscope and linked to a
ell computer and analyzed using the MetaMorph image analysis
ystem. For cell counts, mesenchymal cell nuclei (i.e., those nuclei
hich were at least three nuclear diameters away from the endo-
ardial and myocardial layers) were quantitated in 5–7 sections and
veraged. Every other section was analyzed to avoid counting a
iven nucleus more that once. The data were expressed as nuclei/
ection for both treated and control samples.
For immunostaining, frozen sections of inhibitor-treated and
ontrol embryos were blocked in 1X TBST containing 10% normal
oat serum. Immunofluorescence studies were performed using
ouse monoclonal anti-smooth muscle actin antibody (1/100
ilution), or undiluted anti-type IV collagen hybridoma superna-
ant. The secondary antibody was a FITC-conjugated goat anti-
ouse IgG (1/200). Sections with mounted using Vectashield
ounting medium with DAPI to stain nuclei. The primary anti-
ody was omitted in controls.
In Situ Hybridization
Mouse embryos (C57Bl6J) were used for in situ hybridization
rather than quail as the available probes for type IV collagen were
mouse specific. Embryos of 9.5 days gestation were fixed in 4%
paraformaldehyde for 2–4 h, frozen in OCT compound, and sec-
tioned. The heart at this stage of mouse development was roughly
equivalent to that of the stage 14–15 quail (i.e., early EMT stage).
Sections containing the heart were labeled with 35S-labeled sense
and antisense riboprobes as described previously (Alexander et al.,
997). Riboprobes were synthesized from the linearized mouse a1
type IV collagen cDNA kindly provided by Dr. Yoshi Yamada
(Oberbaumer et al., 1985). Following hybridization and posthybrid-
ization treatments, the sections were coated with Kodak NTB2
nuclear track emulsion and exposed for 15 days. The developed
slides were examined and photographed using darkfield optics.
Proteinase Activity Measurements
The level and activation state of MMP-2 in hearts of inhibitor-
treated and control embryos were examined by zymography.
Hearts were collected from control and inhibitor-injected embryos
at stage 18 and extracted overnight at 4°C in 0.1 M phosphate
buffer containing 0.02% NaN3 and 0.01% Triton X-100 at pH 8.0.
liquots were removed for total protein determination using the
icroBCA assay (Pierce), and for electrophoresis in 10% polyacryl-
mide minigels into which gelatin (1 mg/ml) was crosslinked.
ollowing electrophoresis, the gels were soaked for 15 min in 2.5%
riton X-100 and rinsed well with water. The gels were incubated
or 48 h in LSCB buffer (100 mM Tris, 5 mM CaCl2, 0.005% Brij-35,
.001% NaN3, pH 8.0) and stained with Coomassie. Zones of
clearing corresponding to the presence of proteinase in the gel were
quantitated using the Alpha Imager 2000 (Alpha Innotech Corp.,
San Leandro, CA). The area of the lysis zone was expressed as the
integrated density value.
Copyright © 2000 by Academic Press. All rightThe effectiveness of the MMP inhibitor was determined in live
tissues and cells using a H3 type IV collagen release assay. Tissue
culture wells were incubated overnight at 4°C with approximately
15,000 cpm of H3 type IV collagen (0.1–1 mCi/mg, New England
Nuclear, Boston MA) and rinsed extensively with PBS. Nonbound
sites were blocked with BSA. Explants of the stage 15–16 AVC
(described below) were placed onto the substrate and incubated
overnight in the presence or absence of the MMP inhibitors. The
percentage of released counts (indicating degraded type IV collagen)
was determined from the total counts in the conditioned media and
the counts remaining bound to the tissue culture wells. Bound
counts were determined by extracting the wells with 10% SDS at
the end of the incubation period. Nonspecific release (wells with-
out AVC explants) was minimal (#1.5% of the total counts) and
was subtracted from the media-derived counts. Released counts
were analyzed by ultrafiltration using a Centricon-50 (Amicon,
Beverly, MA) to confirm that the majority of the released counts
represented small fragments of the protein.
Explant Culture and Motility Analysis
Endocardial cushion-derived cells were obtained from explants
of the AVC of stage 15–16 quail embryos. The AVC was removed
from intact hearts and opened longitudinally with a pair of sharp-
ened needles and placed endocardial-side down onto the appropri-
ate substrates and incubated in M199 medium containing 10%
fetal calf serum and antibiotics. Substrates were prepared by
incubating dishes overnight at 4°C with 100 mg/ml solutions of
type IV collagen, fibronectin, laminin, or tenascin. Nonbound sites
were blocked with a solution of 0.1% BSA at room temperature.
Gelatin-coated dishes were prepared using a 0.1% solution and
air-drying. For motility analysis, the explants were plated onto
coated tissue culture wells and incubated at 37°C in the presence or
absence of 5 mM BB-94 or BB-1722. The extent of cellular out-
rowth after 16 h in culture was quantitatively analyzed using the
etaMorph image analysis system. Comparisons in the extent of
ellular outgrowth from the edges of the explants were made
mong control (no addition), BB-1722-, and BB-94-treated cultures
n the various substrates. The radial distance of migration from the
dge of the explants was determined by measuring the distance at
elect points around the circumference of the explant (0, 45, 90,
35, 180, 225, 270, and 315°). Data were analyzed statistically using
he Student t test and expressed as average micrometer from the
dge of the explant.
Isolated cells were obtained from explants on gelatin-coated
ishes. The explants were removed and the cells were passaged
sing trypsin (0.05%)/EDTA (0.53 mM) and grown in medium
199 containing 10% fetal calf serum and antibiotics.
Growth Factor Regulation of MMP Expression
Isolated cushion tissue cells were transferred to serum-free
medium and treated with 1 or 10 ng/ml of TGFb3 (R&D Systems)
for 16 h. Total RNA was isolated, and cDNA was prepared using
1–2 mg RNA with an oligo(dT)primer and Superscript reverse
transcriptase (Gibco BRL). For semiquantitative PCR, 1 mL of first
strand reaction was amplified using oligonucleotide primers spe-
cific for the chicken MT-MMP, MMP-2, and GAPDH (see below).
PCR conditions were optimized for each set of primers so as to be
within the linear range of amplification. For MT-MMP the condi-
tions were 94°C 1 min, 65°C 1 min, and 72°C 1 min for 30 cycles.
For MMP-2 and GAPDH the PCR conditions were 94°C 1 min,
s of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All right60°C 1 min, and 72°C 1 min for 25 cycles. Upon completion, 10 mL
f the PCR was analyzed by agarose gel electrophoresis and
isualized by cyber green staining. Quantitation of band density
as accomplished using the Alpha Imager 2000 analysis software
Alpha Innotech Corp., San Leandro, CA). The primer sets for these
nalyses were as follows: chicken MT-MMP (375-bp product),
9-AGAATCACCCCAGGGAGCCTTTGT-39 and 59-GATCTCA-
CCACTCTTGCATAG AGCGT-39; chicken MMP-2 (413-bp prod-
uct); 59-AAATCGATATGGTCTACGAGTCCCT-39 and 59-GGATC-
GATTTCAGCAACCCAACCAGT-39; and chicken GAPDH (350-bp
product), 59-ACCATCAAGTCCACAACACG-39 and 59-AAGGTC
ATCCCAGAGCTGAA-39. Data were reported as the mean inte-
grated density value from three independent experiments. Statistical
analysis was done by the Student t test, and values were expressed as
the mean 6 standard error of the mean. Tests were considered
statistically significant at P values of #0.05.
RESULTS
Stage 12 quail embryos were grown in a shell-less culture
system and microinjected with 50 nl (5 mM) of either BB-94
or BB-1722 in PBS/0.01% fast green. Control embryos
received an injection of the equivalent volume of PBS/fast
green. Injections were given directly into the ventricular
portion of the heart and the embryos were returned to the
incubator until stage 18 or 24 of development. The majority
of injected embryos tolerated the injection well and devel-
oped further. Of those embryos that died following the
injection, most appeared to do so because of excessive
bleeding from the injection site.
By stage 18 of development in the quail, a significant
number of mesenchymal cells are present in the extracel-
lular matrix of the endocardial cushions in control embryos
(Fig. 1A). The number of mesenchymal cells in the cushions
was determined from serial sections of the AVC and ex-
pressed as the number of nuclei/section. No significant
difference was found in the number of nuclei/section for
embryos injected with either PBS/fast green or BB-1722
(Figs. 1A and 1C). In contrast, a significant decrease was
seen in the number of mesenchymal cells present in the
cushion extracellular matrix in embryos receiving an injec-
tion of the matrix metalloproteinase inhibitor BB-94 (Figs.
1B and 1C). The majority of mesenchymal cells appeared to
be confined to a region very close to the endocardial lining
of the AVC with a few scattered or clustered cells present in
areas separated from the endocardial lining (Fig. 1B). This
was in contrast to those embryos treated with either vehicle
or BB-1722, which exhibited mesenchymal cells evenly
distributed throughout the endocardial cushion.
chyme formed and what is present appears to remain close to the
endocardium and does not migrate into the cushion matrix. M,
myocardium. Bar 5 100 mm. (C) Quantitative analysis of mesen-
chyme formation. Values are the mean 6 the SEM. *SignificantlyFIG. 1. Inhibition of matrix metalloproteinase activity prevents
mesenchyme formation in the endocardial cushions of the AVC.
Representative sections of the AVC from stage 18 quail embryos
injected at stage 12 with either BB-1722 (A) or BB-94 (B). In the
BB-1722-injected animals, numerous mesenchymal cells (ms) have
migrated from the endocardium (E) into the surrounding cardiac
jelly matrix of the cushion. This is in contrast to those animalsdifferent from PBS and BB-1722-injected animals at the P , 0.05 level.
s of reproduction in any form reserved.
i610 Song, Jackson, and McGuireIn some cases embryos were allowed to develop to stage
24 following the injection of inhibitor at stage 12–14. At
this later stage of development in the control embryos, the
AVC cushions are so densely populated with mesenchymal
cells that they could not be accurately quantitated. The
effect of BB-94 on the formation of AVC cushion mesen-
chyme appeared to be temporary as the number of cells was
increased significantly in the stage 24 embryos treated with
BB-94 compared to those examined at stage 18. (Fig. 1C).
To determine if BB-94 were nonspecifically inhibiting the
initiation of the EMT process, embryos injected with BB-94
at stage 12–14 were fixed at stage 18 and immunostained
using an antibody to smooth muscle a-actin, a marker of
cells which have undergone the transformation process
(Deruiter et al., 1997; Nakajima et al., 1999). Sections of the
AVC from BB-94 injected embryos treated with this anti-
body showed that the endocardium had initiated the trans-
formation process, and that the cells which were present
either in the matrix or adjacent to the endocardial lining
were expressing the mesenchymal cell phenotype (Fig. 2).
We have shown previously that only two members of the
MMP family are detected in the heart of the developing
quail embryo, MMP-2 and MT1-MMP (Alexander et al.,
1997). During the epithelial-mesenchymal transformation,
the amount of active MMP-2 was found to increase signifi-
cantly, presumably due to the action of MT-MMP on the
proenzyme form of the proteinase. The hearts from em-
bryos injected with either BB-1722 or BB-94 were analyzed
at stage 18 by zymography to characterize the stage of
MMP-2 within the tissue. The amount of the 64-kDa active
form of MMP-2 was significantly less in BB-94-treated
embryos compared to those treated with the control com-
FIG. 2. BB-94 inhibition of matrix metalloproteinase activity doe
expression of smooth muscle a-actin in transforming endocardial c
the AVC from a stage 18 embryo injected with BB-94 at stage 12. T
mesenchyme that has formed (arrow) and the endocardium (E) a
Individual cells are identified by blue nuclear staining. M, myocar
n (A). Bar 5 40 mm.s not disrupt the initial events of the EMT process as evidenced by the
ells and mesenchyme. (A) Immunolabeling of smooth muscle a-actin in
he number of mesenchymal cells is greatly reduced; however, both the
re stained positively for smooth muscle a-actin (green fluorescence).
dium. Bar 5 66 mm. (B) Higher magnification of the endocardial regionpound BB-1722 (Fig. 3). Those embryos injected with ve-
Copyright © 2000 by Academic Press. All rightFIG. 3. BB-94 injection decreases the amount of the active form of
MMP-2 in the stage 18 heart. (A) Zymographic analysis of hearts
from BB-1722-injected (Lane 1) and BB-94-injected (Lane 2) em-
bryos. The position of the 72-kDa pro-form of MMP-2 is indicated.
(B) Quantitative analysis of the pro- (72 kDa) and active (64 kDa)
forms of MMP-2 from zymograms indicates a significant reduction
in the level of active MMP-2 in embryos injected with BB-94.
s of reproduction in any form reserved.
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611Matrix Metalloproteinases in the Developing Hearthicle only were no different from BB-1722-injected embryos
(data not shown). No changes were seen in the level of the
inactive 72-kDa pro-form of the enzyme.
The degree to which the cushion becomes populated with
mesenchymal cells is due in part to the migration of
transformed cells from the endocardial lining, as well as to
the proliferation of existing mesenchymal cells. In vitro
explant studies were subsequently carried out to determine
if the inhibition of MMP-2 activity disrupted mesenchymal
cell migration. Explants of the AVC from stage 15–16
embryos were placed endocardial-side down onto a gelatin-
coated substrate and incubated overnight in the presence of
either BB-1722 (Fig. 4A) or BB-94 (Fig. 4B). In control
FIG. 4. BB-94 inhibits the in vitro outgrowth of endocardial-
derived cells (endocardium and mesenchyme) from AVC explants.
(A) AVC explants (E) grown on gelatin-coated substrates in the
presence of 5 mM BB-1722 show an extensive outgrowth of cells
after 16 h in culture. (B) AVC explant (E) grown on gelatin in the
presence of BB-94 demonstrates a significant reduction in the
extent of cellular outgrowth after 16 h. Bar 5 300 mm.cultures the endocardial-derived cells (a portion of which B
Copyright © 2000 by Academic Press. All rightre transformed mesenchyme) migrated extensively from
he edges of the explant. In contrast, far fewer cells migrated
utward from the explants treated with the same concen-
ration of BB-94. Quantitation of the migration distance
evealed that control cells migrated approximately 500 mm
from the edge of the explant on average, compared to
approximately 200 mm for cells treated with BB-94 (Fig. 5).
MMP-2 may selectively regulate the ability of cushion
tissue cells to interact with and migrate on specific extra-
cellular matrix molecules. This possibility was investigated
by placing AVC explants onto substrates of gelatin, fi-
bronectin, type IV collagen, laminin, and tenascin in the
presence of BB-1722 or BB-94. The explants were incubated
for 16 h and the extent of cellular outgrowth was quanti-
tated (Fig. 5). Significant inhibition of cell migration was
observed for explants plated onto either gelatin or type IV
collagen substrates and grown in the presence of BB-94
compared to BB-1722. No significant difference in out-
growth was seen for explants grown on fibronectin or
laminin, while tenascin did not appear to provide a useful
substrate for outgrowth in either case.
To confirm that the effect seen in these experiments
resulted from an inhibition of MMP-2 activity, explants
were plated onto a substrate of radiolabeled type IV collagen
and analyzed for the release of radioactive counts. Explants
grown in either the presence of BB-1722 or no additions to
the media released between 20 and 22% of the total
radioactivity bound to the substrate (Table 1). When ex-
plants were grown in the presence of equivalent concentra-
tions of BB-94, the percentage of released radioactivity
dropped to approximately 6%.
FIG. 5. Matrix metalloproteinases selectively regulate the inter-
actions of endocardial-derived cells with components of the extra-
cellular matrix. AVC explants were cultured on the indicated
substrates for 16 h in the presence of either BB-1722 or BB-94 and
the extent of outgrowth was determined. Values are the mean 6
EM from three separate experiments. *Significantly less than
B-1722-treated cultures at the P , 0.05 level.
s of reproduction in any form reserved.
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612 Song, Jackson, and McGuireThe above data suggest that type IV collagen serves as a
permissive substrate for endocardial/mesenchymal cell mi-
gration only if active MMP-2 and MT-MMP are present and
the type IV collagen is degraded.
The site of type IV collagen synthesis in the endocardial
cushions was determined by in situ hybridization with a
probe to the a1 chain of the protein. Both the endocardium
and myocardium appear to express the mRNA for this
component of the basement membrane (Fig. 6). The type IV
collagen protein was further localized in the cushions by
immunostaining. Sections of the AVC from control, un-
treated embryos were immunostained with the IIb12 anti-
body at a stage prior to the initiation of the EMT (Stage 12).
The basement membrane underlying the endocardium as
well as that associated with the myocardium was intensely
stained (Figs. 7A and 7B). In addition, a diffuse punctate
pattern of type IV collagen staining was also evident in the
cardiac jelly matrix. In control embryos during the early
stages following the initiation of the EMT (stage 16), the
discrete pattern of type IV collagen remained associated
with the myocardium but was conspicuously absent from
the endocardial lining (Figs. 7E and 7F). On occasion, some
fibrillar type staining was seen associated with groups of
mesenchymal cells. In embryos treated with BB-94 at stage
12–14 and examined later at stage 18, the staining associ-
ated with the endocardium and cardiac jelly appeared to
persist (Figs. 7C and 7D).
A final set of experiments was carried out to determine if
growth factors, known to play an important role in the
regulation of the EMT, have the ability to regulate MMP
expression in the cushion tissue cells. One growth factor
which has been shown to influence the formation of mes-
enchyme in the endocardial cushions is TGFb3 (Ramsdell
ABLE 1
B-94 Inhibits the Degradation of Type IV Collagen by
ndocardial Cushion-Derived Cells
Total No
of explants Treatment cpm media cpm bound
% cpm
released
17 No addition 1975.5 6 103 7034 6 334 22.0
20 BB-1722 (100
mg/ml)
1689.7 6 175 6831 6 212 20.0
20 BB-94 (100
mg/ml)
562.3 6 113 8786 6 303 6.0*
Note. Explants were plated onto H3 type IV collagen substrate
nd incubated in media for 16 h with the indicated additions.
edia were collected and total cpm were determined. cpm remain-
ng bound to the substrate were removed by incubation with 10%
DS. Values are the mean 6 SEM for the total number of explants
ndicated from two experiments after subtracting the values for
edia only control.
*Significantly less than no addition and BB1722 at the P # 0.05
evel.and Markwald, 1997; Yamagishi et al., 1999; Boyer et al.,
Copyright © 2000 by Academic Press. All right1999; Nakajima et al., 2000). Isolated cushion tissue cells
were incubated overnight with 1 or 10 ng/ml of TGFb3 and
nalyzed by RT-PCR. The mRNA for both MT-MMP and
MP-2 were found to increase significantly in these cells in
esponse to TGFb3 stimulation when compared to un-
reated controls (Figs. 8 and 9).
DISCUSSION
This study is an extension of previous work from our
laboratory which initially characterized the expression of
MMPs in the endocardial cushions of the developing avian
heart, and suggested that the activity of these enzymes was
necessary for the migration of mesenchyme into the cardiac
jelly matrix. We now provide evidence that degradation of
FIG. 6. In situ hybridization analysis of type IV collagen expres-
sion in the 9.5 day mouse embryo. Expression of type IV collagen
mRNA is seen in both the endocardium (E) and the myocardium
(M) of an antisense-treated section (A). Adjacent section treated
with a sense probe gave no specific labeling (B). Bar 5 100 mm.
s of reproduction in any form reserved.
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613Matrix Metalloproteinases in the Developing Hearttype IV collagen in the endocardial basement membrane by
MMPs is critical for mesenchyme formation during the
epithelial-mesenchymal transformation process.
Embryos injected with the hydroxamic acid-based MMP
inhibitor BB-94 showed significantly less mesenchyme for-
mation than embryos receiving either an injection of ve-
hicle alone or an injection of a nonactive form of the
inhibitor (BB-1722). The BB-94 inhibitor has been shown to
have broad specificity for members of the MMP family but
lacks activity against a number of other metalloproteinases
(Brown and Giavazzi, 1995). This inhibitor exhibits activity
in the low micromolar range and has been shown to
decrease angiogenesis and to inhibit tumor growth, inva-
sion, and metastasis in a number of animal models (Tarabo-
letti et al., 1995; Watson et al., 1995; Wojtowicz-Praga et
l., 1996). The specificity of the BB-94 effect was demon-
trated by the use of BB-1722 in embryos. BB-1722 is the
nantiomer of BB-94 and showed no inhibition of mesen-
hymal cell migration. In addition, the effect of BB-94 was
hown to be partially reversible as embryos examined 2
ays following a single injection demonstrated significant
utgrowth of mesenchyme into the cushions. This result
ay have been due to a relatively short half-life of the
ompound in the animal. Because of the apparent short
alf-life and the limited life span of the cultured embryos, it
ould be difficult to determine if MMP inhibition and
ecreased mesenchyme migration have a detremental effect
FIG. 7. Type IV collagen immunostaining in the AVC (B, D, and
tage 12 unmanipulated embryos (A and B) demonstrate a distinct
nd the myocardium (m). Type IV collagen staining associated wit
MT at stage 16 (E and F). Embryos treated with BB-94 at stage 12
V associated with the endocardium (C and D). Bar 5 50 mm.n subsequent septation events in the heart. Answers to d
Copyright © 2000 by Academic Press. All righthis question may be obtained in studies which provide
ustained delivery of these compounds to embryos in ovo.
The results of this study suggest that decreased levels of
MP-2 activity may negatively affect the normal EMT
ccurring in the developing endocardial cushions. This is in
ontrast, however, to reports of mice which lack MMP-2
nd still apparently form mesenchyme normally (Itoh et al.,
997, 1998). This difference may reflect a compensatory
esponse in the null embryos to the lack of MMP-2 proen-
yme expression involving the upregulation of other extra-
ellular proteinases which may serve the same purpose. If
his is the appropriate response, it would not be expected to
ccur in the embryos in this study which were injected
ith the inhibitor. This in fact was the case, as the level of
roenzyme expression in inhibitor-treated animals re-
ained at control levels.
In addition to inhibiting the activity of MMP-2, BB-94
ould also be expected to inhibit the activity of other
MPs present in the developing heart including MT1-
MP. This was confirmed by the significant decrease in the
mount of the low molecular weight active form of MMP-2
een in the BB-94-injected embryos. Numerous studies have
emonstrated that one of the primary functions of MT-
MP is the activation of proMMP-2 (Ailenberg and Silver-
an, 1996; Butler et al., 1997; Sato et al., 1997). The
ossibility also exists that the inhibition of MT-MMP by
B-94 also affects mesenchymal cell outgrowth indepen-
e corresponding DAPI image is shown in A, C, and E. Sections of
of type IV collagen associated with both the endocardium (arrow)
endocardium appears to disappear following the initiation of the
examined at stage 18 demonstrate the continued presence of typeF). Th
band
h the
andent of a loss of MMP-2 activity. Recent studies have
s of reproduction in any form reserved.
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614 Song, Jackson, and McGuireshown that the MT-MMPs have the ability to directly
degrade many components of the ECM including fibronec-
tin, tenascin, nidogen, aggrecan, perlecan, and types I and III
collagen (D’Ortho et al., 1997; Ohuchi et al., 1997). In
ontrast to the MMP-2 knockout, loss of MT1-MMP in
ice resulted in significant phenotypic changes associated
ith the skeletal system related to an inability to remodel
atrices containing high amounts of interstitial collagen.
his is likely due in large part to the role of MT1-MMP in
he activation of procollagenase. Since the heart and other
rgans apparently developed normally in these animals,
his again suggests that other proteolytic pathways com-
ensated for the loss of MT1-MMP function, or that the
ctivation of proMMP-2 may not be exclusively via MT1-
MP (Holmbeck et al., 1999; Mazzieri et al., 1997; Zucker
t al., 1995).
The extracellular matrix composition of the endocardial
FIG. 8. RT-PCR analysis of MMP-2 expression in isolated endo-
cardial cushion cells. (A) Representative agarose gel demonstrating
the expression of MMP-2. Lane 1, no treatment; Lane 2, TGFb3 at
1 ng/ml; Lane 3, TGFb3 at 10 ng/ml. Cells treated with either 1 or
0 ng/ml TGFb3 showed an increased expression of MMP-2 mRNA
fter 16 h of stimulation (B). *Significantly greater than control.
alues are the mean 6 SEM.ushions has been well characterized and the migration of t
Copyright © 2000 by Academic Press. All rightesenchymal cells into the cardiac jelly matrix likely
nvolves structural alterations of some of these matrix
omponents. Using an in vivo culture system we have
hown that the ability of cushion-derived cells to migrate
n specific substrates is dependent upon the activity of
MP-2 and MT1-MMP. In particular, type IV collagen did
ot act as a suitable migratory substrate when MMP activ-
ty was inhibited. This suggests that the intact type IV
ollagen molecule facilitates the strong attachment of cells,
ut that the protein must be degraded to some extent in
rder for the cells to demonstrate migratory activity. A
imilar process has been reported in the migration of breast
pithelial cells on laminin-5 substrates (Giannelli et al.,
997). Cleavage of a portion of the laminin-5 protein by
MP-2 produced fragments with pro-migratory activity for
his cell type. Numerous ECM proteins have been shown to
ontain such “cryptic” information which effects both
CM organization as well as cell-ECM interactions (Davis,
FIG. 9. RT-PCR analysis of MT-MMP expression in isolated
endocardial cushion cells. (A) Representative agarose gel demon-
strating the expression of MT-MMP. Lane 1, no treatment; Lane 2,
TGFb3 at 1 ng/ml; Lane 3, TGFb3 at 10 ng/ml. Cells treated with
ither 1 or 10 ng/ml TGFb3 showed an increased expression of
MP-2 mRNA after 16 h of stimulation (B). *Significantly greaterhan control. Values are the mean 6 SEM.
s of reproduction in any form reserved.
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615Matrix Metalloproteinases in the Developing Heart1992; Montgomery et al., 1994; Fukai et al., 1995, 1997;
Barshavit et al., 1995; Smith et al., 1996, 1997; Zhang et al.,
1998). Although not reported, cryptic sites may also exist
within type IV collagen which provide positive migratory
cues or substrates for cells. These data suggest that the
proteolytic modification of the matrix not only removes
physical barriers to cell migration, but may also create new
information previously embedded in the matrix with which
the cell can interact.
The proteolytic alteration of type IV collagen, and per-
haps other basement membrane components, appears to be
a prerequisite for the migration of transformed cells from
the endocardial layer into the surrounding cardiac jelly
matrix. Previous immunohistochemical studies have
shown that type IV collagen is present as a continuous layer
beneath the endocardial lining in the AVC and becomes
more intermittent as development progresses and the endo-
cardium undergoes the EMT (Kitten et al., 1987; Nakajima
t al., 1997). We have utilized an antibody to chicken type
V collagen (IIB12) which recognizes an epitope close to the
S region of the protein and adjacent to the proteolytic
leavage site. This antibody is useful for identifying areas in
he tissue in which the IIB12 epitope is lost due to the
egradation of type IV collagen (Ryan et al., 1999). Treat-
ent of embryos with BB-94 prior to the onset of the EMT
emonstrated maintenance of the endocardial-associated
ype IV collagen and the lack of mesenchymal cell migra-
ion. Together with the in situ hybridization data, this
ould suggest that the endocardium initially produces a
arrier to cell migration which requires a subsequent signal
rom the myocardium or other sources in order for the EMT
o occur normally.
The EMT which occurs in the developing endocardial
ushions involves a discrete series of steps which are
egulated by identified growth factor signals, produced by
oth the myocardium and the endocardium. A recent report
emonstrates that TGFb2 is primarily involved in the early
phases of the EMT by regulating the induction of Slug
expression (Romano and Runyan, 2000). This transcription
factor has been shown to play an important role in facili-
tating the loss of cell-cell adhesion through the disruption
of desmosomes between adjacent cells (Savagner et al.,
1997). The later steps of the EMT involve the migration of
endocardial cells into the underlying cardiac jelly matrix
and appear to be regulated by a different set of growth
factors including TGFb3, BMP, and HGF (Romano and
unyan, 2000).
The migration of cushion mesenchyme is facilitated by
he production of extracellular proteinases, and the identi-
ed growth factors are likely to be involved in the regula-
ion of their expression and activation. We have previously
hown that HGF is produced by the myocardium and
egulates urokinase expression in the endocardium (Song et
l., 1999), and other reports demonstrate a positive effect of
his growth factor on MMP expression (Wang and Keiser,
000; Hamasuna et al., 1999). Results from the present
tudy also demonstrate the ability of TGFb3 to regulate the
Copyright © 2000 by Academic Press. All rightxpression of both MMP2 and MT1-MMP in endocardial-
erived cells. This suggests that abnormalities in cardiac
ushion development as a result of alterations in growth
actor expression and/or activity may be partially mediated
hrough disrupted proteinase expression in endocardial
nd/or mesenchyme cells.
In summary, we have presented data to suggest an impor-
ant role for MMP-2 and MT-MMP in facilitating the
igration of endocardial-derived mesenchyme during the
MT. The persistence of type IV collagen in the endocardial
asement membrane, and the lack of migration of trans-
ormed cells in embryos treated with a synthetic matrix
etalloproteinase inhibitor, suggests that type IV collagen
ay present an initial barrier which must be overcome by
he forming mesenchymal cells. This proteolytic event may
lay a role in establishing a matrix-induced signaling path-
ay, dependent upon the generation of ECM protein frag-
ents, required for normal cell migration. These data
urther suggest that the expression and activation of spe-
ific matrix metalloproteinases are necessary for the nor-
al morphogenesis of the heart, and that alterations in the
evels of active enzymes may be a mechanism leading to the
evelopment of specific developmental defects associated
ith this organ.
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